Publications by authors named "Thomas Armor"

Claim this Profile
E
Efficacy and Safety of High-Specific-Activity I-MIBG Therapy in Patients with Advanced Pheochromocytoma or Paraganglioma.
Daniel A Pryma, Bennett B Chin, Richard B Noto, Joseph S Dillon, Stephanie Perkins, Thomas Armor

J Nucl Med· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intraindividual Comparison of Tc-Methylene Diphosphonate and Prostate-Specific Membrane Antigen Ligand Tc-MIP-1427 in Patients with Osseous Metastasized Prostate Cancer.
Hendrik Rathke, Ali Afshar-Oromieh, Frederik Lars Giesel, Christophe Kremer, Paul Flechsig, Thomas Armor

J Nucl Med· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 Study of Tc-Trofolastat SPECT/CT to Identify and Localize Prostate Cancer in Intermediate- and High-Risk Patients Undergoing Radical Prostatectomy and Extended Pelvic LN Dissection.
Karolien E Goffin, Steven Joniau, Peter Tenke, Kevin Slawin, Eric A Klein, Thomas Armor

J Nucl Med· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repeated PSMA-targeting radioligand therapy of metastatic prostate cancer with I-MIP-1095.
Ali Afshar-Oromieh, Uwe Haberkorn, Christian Zechmann, Thomas Armor, Walter Mier

Eur J Nucl Med Mol Imaging· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
9
99mTc-labeled small-molecule inhibitors of prostate-specific membrane antigen: pharmacokinetics and biodistribution studies in healthy subjects and patients with metastatic prostate cancer.
Shankar Vallabhajosula, Anastasia Nikolopoulou, John W Babich, Joseph R Osborne, Scott T Tagawa, Thomas Armor

J Nucl Med· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase-1 clinical trial results of high-specific-activity carrier-free 123I-iobenguane.
Bennett B Chin, James F Kronauge, Frank J Femia, Jianqing Chen, Kevin P Maresca, Thomas Armor

J Nucl Med· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-man evaluation of 2 high-affinity PSMA-avid small molecules for imaging prostate cancer.
John A Barrett, R Edward Coleman, Stanley J Goldsmith, Shankar Vallabhajosula, Neil A Petry, Thomas Armor

J Nucl Med· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis